Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)
· seekingalpha.com
Eli Lilly (LLY) leads the global obesity drug market vs Novo Nordisk as competition heats up.
Obesity drug investors in Eli Lilly ( LLY ) are riding high and I think they deserve it. After the stock bottomed out in May this year, it hasn't looked back
J...